Susquehanna International Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-21,561
Closed -$100K 11222
2019
Q1
$100K Sell
21,561
-14,786
-41% -$70K ﹤0.01% 8250
2018
Q4
$127K Buy
+36,347
New +$253K ﹤0.01% 8093
2018
Q3
Sell
-59,757
Closed -$477K 10762
2018
Q2
$433K Sell
59,757
-42,712
-42% -$298K ﹤0.01% 7088
2018
Q1
$619K Sell
102,469
-17,139
-14% -$142K ﹤0.01% 6209
2017
Q4
$1.15M Buy
+119,608
New +$783K ﹤0.01% 4947
2017
Q3
Sell
-28,112
Closed -$290K 10056
2017
Q2
$356K Buy
+28,112
New +$333K ﹤0.01% 7264
2017
Q1
Sell
-84,523
Closed -$901K 10538
2016
Q4
$778K Buy
+84,523
New +$955K ﹤0.01% 6049
2016
Q3
Sell
-89,427
Closed -$1.36M 9377
2016
Q2
$1.16M Buy
89,427
+57,730
+182% +$841K ﹤0.01% 4564
2016
Q1
$507K Buy
+31,697
New +$602K ﹤0.01% 6376
2015
Q4
Sell
-65,637
Closed -$1.82M 10271
2015
Q3
$1.87M Buy
65,637
+55,463
+545% +$2.04M ﹤0.01% 4406
2015
Q2
$365K Buy
+10,174
New +$317K ﹤0.01% 8211
2014
Q4
Sell
-30,086
Closed -$595K 10330
2014
Q3
$583K Buy
30,086
+16,200
+117% +$254K ﹤0.01% 6938
2014
Q2
$217K Buy
+13,886
New +$224K ﹤0.01% 8931

Other funds holding INSY

Susquehanna International Group's INSY Position: Q2 2019 in Review

Susquehanna International Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 21,561 shares — an estimated $100K sold.

Susquehanna International Group first reported a position in INSY in Q2 2014 and held it in 13 quarters. The position peaked at $1.87M in Q3 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Susquehanna International Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Susquehanna International Group sold 21,561 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $100K.
  • Susquehanna International Group first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 13 quarters.
  • Susquehanna International Group's Insys Therapeutics, Inc. position peaked at $1.87M in Q3 2015.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.